JPH0587048B2 - - Google Patents

Info

Publication number
JPH0587048B2
JPH0587048B2 JP62053872A JP5387287A JPH0587048B2 JP H0587048 B2 JPH0587048 B2 JP H0587048B2 JP 62053872 A JP62053872 A JP 62053872A JP 5387287 A JP5387287 A JP 5387287A JP H0587048 B2 JPH0587048 B2 JP H0587048B2
Authority
JP
Japan
Prior art keywords
solution
obesity
days
cells
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP62053872A
Other languages
English (en)
Japanese (ja)
Other versions
JPS63218621A (ja
Inventor
Kazuoki Tsucha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP5387287A priority Critical patent/JPS63218621A/ja
Publication of JPS63218621A publication Critical patent/JPS63218621A/ja
Publication of JPH0587048B2 publication Critical patent/JPH0587048B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP5387287A 1987-03-09 1987-03-09 肥満症の予防・治療用組成物 Granted JPS63218621A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5387287A JPS63218621A (ja) 1987-03-09 1987-03-09 肥満症の予防・治療用組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5387287A JPS63218621A (ja) 1987-03-09 1987-03-09 肥満症の予防・治療用組成物

Publications (2)

Publication Number Publication Date
JPS63218621A JPS63218621A (ja) 1988-09-12
JPH0587048B2 true JPH0587048B2 (enExample) 1993-12-15

Family

ID=12954841

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5387287A Granted JPS63218621A (ja) 1987-03-09 1987-03-09 肥満症の予防・治療用組成物

Country Status (1)

Country Link
JP (1) JPS63218621A (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2234412C (en) 1997-06-09 2008-09-02 Kyowa Hakko Kogyo Co., Ltd. Method for producing optically active compound
WO2004083179A1 (ja) * 2003-03-19 2004-09-30 Kyowa Hakko Kogyo Co., Ltd. 糖尿病治療剤
CA2520007A1 (en) * 2003-03-26 2004-10-07 Kyowa Hakko Kogyo Co., Ltd. Lipid metabolism improving agent
CA2520375A1 (en) * 2003-03-28 2004-10-14 Kyowa Hakko Kogyo Co., Ltd. Anti-obesity agent
CA2600954A1 (en) * 2005-03-22 2006-12-14 Innodia Inc. Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
WO2007105730A1 (ja) * 2006-03-13 2007-09-20 Kyowa Hakko Kogyo Co., Ltd. インスリン抵抗性改善剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2207702B1 (enExample) * 1972-11-23 1975-11-28 Rhone Poulenc Ind
US4692458A (en) * 1980-03-05 1987-09-08 University Of Miami Anti-hypertensive agents

Also Published As

Publication number Publication date
JPS63218621A (ja) 1988-09-12

Similar Documents

Publication Publication Date Title
RU2283108C2 (ru) ГЕРОПРОТЕКТОР НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО(4,3-b) ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ
JP5956664B2 (ja) 脂肪異栄養症の処置
Awadzi et al. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis
JPH02233610A (ja) 血管新生阻害剤
BG63612B1 (bg) Състав и метод за профилактика и лечение на нiv идруги инфекциозни заболявания при човека
EP1319402A1 (en) Ige production inhibitors
US10596224B2 (en) Method of treating a wound, comprising the step of administering a composition including a substance P
LT4751B (lt) Tizoksanido ir nitazoksanido farmacinės kompozicijos
Awadzi et al. The chemotherapy of Onchocerciasis VIII: levamisole and its combination with the benzimidazoles
JPH0587048B2 (enExample)
Williams et al. Gangrene of the feet in diabetics
Wolinsky Chemotherapy and pathology of experimental photochromogenic mycobacterial infections
CN117257808B (zh) 吴茱萸次碱在制备促进伤口愈合的产品中的应用
JP2009114101A (ja) 歯周病の予防又は治療用の医薬組成物、口腔衛生剤、並びに食品組成物
JP7364839B2 (ja) 創傷治癒を促進する医薬品の製造におけるカンナフラビンａの使用
CN102631663B (zh) 一种治疗男性不育、阳痿早泄的制剂及其应用
JPH0995445A (ja) 脳神経細胞障害に対する治療薬
JP2021519769A (ja) 皮膚障壁機能異常の改善用組成物
JP2004522783A (ja) 性的機能不全を予防および治療するための医薬の製造におけるｎ−アセチル−ｄ−グルコサミンの使用
FR2605884A1 (fr) Nouvelle association medicamenteuse
CN109010350B (zh) 长梗冬青苷在制备抗糖尿病皮肤溃疡药物中的应用
KR20080074583A (ko) 히알루론산으로 이루어지는 알러지 질환 예방 및 치료용약제, 식품 및 화장품
CN116492360B (zh) 一种三叶豆苷的用途及相关产品
JP7396585B2 (ja) Ｔｓｌｐ遺伝子発現抑制用、ｉｌ－３３遺伝子発現抑制用、又はフィラグリン産生促進用組成物
Calvert et al. The Houssay Syndrome